Award recordCONTRACT

GRIFOLS USA LLC

PIID 36C26024F0023· VHA· 260-NETWORK CONTRACT OFFICE 20 (36C260)· 6505 · DRUGS AND BIOLOGICALS· FY2024· $288,931 net obligations· UEI D48FNWJCJ5H5· CA

Description

PROLASTIN-C

First action · last action
2023-10-01 · 2024-07-29
Transactions
2
First transaction's obligation
$497,000
Base + all options value (sum of deltas)
$288,931
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
36F79722D0090
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 2 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$497,000$0Base award · 2023-10-01 · this action $497,000 · running total $497,000Modification P00001 · 2024-07-29 · this action -$208,069 · running total $288,931
  • Base2023-10-01+$497,000= $497,000
  • Mod P000012024-07-29-$208,069= $288,931
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2023-10-01+$497,000$497,000PROLASTIN-C
Mod P00001· OTHER ADMINISTRATIVE ACTION2024-07-29−$208,069$288,931PROLASTIN-C

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI D48FNWJCJ5H5)

AwardOffice · PSC / listingNet obligationsFY
36C26026F0015260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$120,000FY2026
36C26026F0037260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$364,000FY2026
36C26026F0019260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$111,000FY2026
36C26025F0153260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$97,176FY2025
36C26025F0037260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$0FY2025
36C26325F0017NETWORK CONTRACT OFFICE 23 (36C263) · 6505 · DRUGS AND BIOLOGICALS$103,293FY2025

Other recipients under 6505 from 260-NETWORK CONTRACT OFFICE 20 (36C260) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C26026F0379COSETTE PHARMACEUTICALS, INC.260-NETWORK CONTRACT OFFICE 20 (36C260)$3,466FY2026
36C26026P0671MCKESSON PLASMA AND BIOLOGICS LLC260-NETWORK CONTRACT OFFICE 20 (36C260)$18,262FY2026
36C26026F0349AGIOS PHARMACEUTICALS, INC.260-NETWORK CONTRACT OFFICE 20 (36C260)$73,080FY2026
36C26026F0306BRACCO DIAGNOSTICS INC.260-NETWORK CONTRACT OFFICE 20 (36C260)$337,422FY2026
36C26026F0298PROGENICS PHARMACEUTICALS INC260-NETWORK CONTRACT OFFICE 20 (36C260)$469,134FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C26024F0023_3600_36F79722D0090_3600 · retrieved 2026-09-26.